HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis
Public ClinicalTrials.gov record NCT03934736. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Single Arm Study, Evaluating the Immunogenicity and Safety of HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis
Study identification
- NCT ID
- NCT03934736
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Dynavax Technologies Corporation
- Industry
- Enrollment
- 119 participants
Conditions and interventions
Interventions
- HEPLISAV-B® Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 21, 2019
- Primary completion
- Oct 22, 2020
- Completion
- Sep 14, 2021
- Last update posted
- Aug 8, 2024
2019 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| DaVita Clinical Research or Affiliate | Bloomfield | Connecticut | 06002 | — |
| DaVita Clinical Research or Affiliate | Middlebury | Connecticut | 06762 | — |
| DaVita Clinical Research or Affiliate | Hollywood | Florida | 33021 | — |
| DaVita Clinical Research or Affiliate | Ocala | Florida | 34471 | — |
| DaVita Clinical Research or Affiliate | Tampa | Florida | 33614 | — |
| DaVita Clinical Research or Affiliate | Winter Park | Florida | 32789 | — |
| DaVita Clinical Research or Affiliate | Jeffersonville | Indiana | 47130 | — |
| DaVita Clinical Research or Affiliate | Roseville | Michigan | 48066 | — |
| DaVita Clinical Research or Affiliate | Edina | Minnesota | 55435 | — |
| DaVita Clinical Research or Affiliate | Minneapolis | Minnesota | 55404 | — |
| DaVita Clinical Research or Affiliate | Kansas City | Missouri | 64111 | — |
| DaVita Clinical Research or Affiliate | Las Vegas | Nevada | 89106 | — |
| DaVita Clinical Research or Affiliate | The Bronx | New York | 10461 | — |
| DaVita Clinical Research or Affiliate | Asheville | North Carolina | 28801 | — |
| DaVita Clinical Research or Affiliate | Canton | Ohio | 44718 | — |
| DaVita Clinical Research or Affiliate | Philadelphia | Pennsylvania | 19106 | — |
| DaVita Clinical Research or Affiliate | El Paso | Texas | 79902 | — |
| DaVita Clinical Research or Affiliate | San Antonio | Texas | 78229 | — |
| DaVita Clinical Research or Affiliate | Norfolk | Virginia | 23510 | — |
| DaVita Clinical Research or Affiliate | Milwaukee | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03934736, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 8, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03934736 live on ClinicalTrials.gov.